$GRWG

[10-Q] GrowGeneration Corp. Quarterly Earnings Report

GrowGeneration Corp. (NASDAQ: GRWG) reported improved financial results in Q1 2026, narrowing its net loss to $4.9 million from $9.4 million year-over-year, while net sales increased by 7.5% to $38.4 million. The growth was driven by both its Cultivation and Gardening and Storage Solutions segments, although gross margin slightly decreased due to a higher mix of lower-margin durable products and inventory actions. The company's liquidity remains solid with $41.1 million in cash, and a $10.0 million share repurchase program was authorized.

Original reporting
Published May 13, 2026, 4:08 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 13, 2026, 4:30 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$GRWG
Neutral
medium confidence
Mentioned
$GRWG
alphai data visualization · based on Stock Titan
Decision brief

The 30-second read

$GRWGNeutralMed
01

Why it matters

The quarterly earnings indicate operational resilience amid margin pressures, which could positively influence investor confidence.

02

Market read

The earnings report provides a moderate positive signal for the company's stock, with potential sector implications.

03

What to watch

Broader industry headwinds, regulatory changes, or supply chain disruptions could adversely affect growth prospects.

Timing: short-term (next 1-2 weeks)

Background

GrowGeneration Corp. operates in the cultivation and gardening supply industry, serving the legal cannabis market.

Company-level read

Ticker impact

$GRWGNeutralMedium confidence
Context

The company's recent quarterly earnings report indicates improved financial performance, which could influence stock price movements.

Expected impact

Potential slight upward movement in stock price over short-term due to improved earnings, but margins and inventory concerns may temper gains.

Evidence & confidence

The earnings beat expectations with reduced losses and increased sales, which are positive indicators. However, margin compression and inventory adjustments could limit upside. Technical indicators and current market conditions are not provided, limiting precise prediction.

Market effects

The retail and wholesale sector, especially specialized in cultivation supplies, may see increased investor interest.

Limited regional impact; company operates primarily in the U.S.

Low; the company is not a global market leader.

Counterpoint

The decline in gross margin and inventory actions could signal underlying operational issues, suggesting a potential downside risk.

Key entities

  • GrowGeneration Corp.

    A retailer and distributor of cultivation and gardening supplies.

  • NASDAQ

    The stock exchange where GRWG is listed.

Related articles

$GRWGMedAI 8/10

GrowGeneration Beats on Q2 Earnings, Hikes '26 Adjusted EBITDA View

GrowGeneration Corp. (GRWG) reported Q2 2026 results: a 3-cent per-share loss, narrower than the Zacks Consensus estimate of a 4-cent loss and versus an 8-cent loss a year earlier. Sales rose 5.5% to $43.2M. Adjusted EBITDA was $0.3M. The company raised full-year adjusted EBITDA guidance to $2–$3M and reaffirmed sales guidance of $162–$168M.

$GRWGMedAI 8/10

GrowGeneration Corp. Q2 2026 Earnings Call Summary

GrowGeneration Corp. reported a third straight quarter of YoY revenue growth, citing a shift to a commercial B2B platform and proprietary brands. Proprietary brand penetration reached 40% ahead of schedule. The company cut store and operating expenses 22% YoY and raised full-year 2026 adjusted EBITDA guidance to $2M-$3M, aided by expected Q3 IEPA tariff refunds. It repurchased 700,000 shares at $1.38.

$GRWGMedAI 8/10

GrowGeneration (GRWG) Q2 2026 Earnings Call Transcript

GrowGeneration (GRWG) reported Q2 2026 revenue of $43.2 million, up 5.5% year over year, with adjusted EBITDA of $0.3 million versus a $1.3 million loss a year earlier. Net loss narrowed to $2.0 million. Gross margin rose to 28.5%. Full-year 2026 guidance: revenue $162-$168 million and adjusted EBITDA $2-$3 million. Cash was $41 million with no debt.

$BNTXMed

BioNTech Ended a Cancer Vaccine Trial. What Does it Mean for its mRNA Strategy?

BioNTech (NASDAQ:BNTX) halted a mid-stage trial of its mRNA cancer vaccine, autogene cevumeran, due to an overall survival imbalance. The decision raises concerns about its mRNA strategy in colorectal cancer and other 'cold' tumors. BioNTech plans to continue other trials, including one for pancreatic cancer and BNT113 for head and neck cancer. The company also focuses on diversifying its oncology pipeline. According to Reuters, the news caused a 7.5% drop in BioNTech's US-listed shares.

$VOW3.DEMed

HISTORIC TURN: Volkswagen To Produce Components For Israel’s Iron Dome System In Germany

Volkswagen (VW) plans to produce components for Israel's Iron Dome missile defense system at its Osnabrück, Germany factory. The move is part of VW's restructuring efforts amid economic challenges and competition. The project involves a joint venture with Israeli defense company Rafael and the German state of Lower Saxony, aiming to overcome opposition from Qatar's sovereign wealth fund, a VW stakeholder. This marks VW's return to defense-related manufacturing as European defense spending rises.

$XOMMed

Piper Sandles Sees ExxonMobil (XOM) Heading Toward New Highs

Piper Sandler raised its price target for ExxonMobil (XOM) to $185, citing strong fundamentals, cost savings, and growth in Guyana. XOM's Q2 earnings beat expectations, with high free cash flow and shareholder returns. However, risks include exposure to Middle East conflicts and potential crude price normalization. XOM's stock has risen 30% in 2026, with a 16% upside implied by the new target.